Functional imaging of intratumoral hypoxia

Molecular Imaging and Biology

Volumn 6, Issue 5, 2004, Pages 291-305

  Foo, Serene S ^a   Abbott, David F ^a   Lawrentschuk, Nathan ^a   Scott, Andrew M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Electron Paramagnetic Resonance Imaging; Functional imaging; Hypoxia; Magnetic resonance imaging; Magnetic resonance spectroscopy; Positron emission tomography

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 2 (2 NITRO 1 IMIDAZOLYL) N (3,3,3 TRIFLUORO 2 HYDROXYPROPYL)ACETAMIDE; 2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; 2 NITROIMIDAZOLE; ANTINEOPLASTIC AGENT; BMS 194769; BRU 59 21; CARBOPLATIN; CISPLATIN; DIACETYLBIS(N4 METHYLTHIOSEMICARBAZONE) COPPER; FLUORINE; FLUORINE 18; FLUOROERYTHRONITROIMIDAZOLE F 18; FLUOROURACIL; GLUCOSE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HYPOXIA INDUCIBLE FACTOR 1; IODOAZOMYCIN ARABINOSIDE IODINE 123; ISOTOPE; MISONIDAZOLE; NITROIMIDAZOLE; NITROXIDE; OXO[3,3,9,9 TETRAMETHYL 1 (2 NITRO 1H IMIDAZOL 1 YL) 4,8 DIAZAUNDECANE 2,10 DIONEDIOXIMATO]TECHNETIUM TC 99M; OXYGEN; PHOSPHORUS 31; PIMONIDAZOLE; SEMICARBAZONE DERIVATIVE; TIRAPAZAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; UPENAZIME TC 99M;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CELL METABOLISM; CLINICAL STUDY; GLIOBLASTOMA; GLUCOSE METABOLISM; HEAD AND NECK CANCER; HUMAN; HYPOXIA; ISOTOPE LABELING; LUNG CANCER; LUNG NON SMALL CELL CANCER; MEDICAL LITERATURE; MEDLINE; METABOLIC PARAMETERS; METASTASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGENATION; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECTROSCOPY; STRESS; TRANSCRIPTION REGULATION; TUMOR; TUMOR GROWTH; TUMOR RESISTANCE;

EID: 4644248790     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mibio.2004.06.007     Document Type: Article

References (149)

1. J. Overgaard M.R. Horsman Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers Semin. Radiat. Oncol. 6 1996 10-21
2. J. Overgaard Overcoming hypoxic cell radioresistance In: G.G. Steel (Ed.) Basic clinical radiobiology for radiation oncologists 1997 Edward Arnold London 141-151
3. J. von Pawel R. von Roemeling U. Gatzemeier Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and tirapazamine in subjects with advanced previously untreated non-small-cell lung tumors J. Clin. Oncol. 18 2000 1351-1359
4. P. Vaupel K. Schlenger M. Hoeckel Blood flow and tissue oxygenation of human tumors: an update Adv. Exp. Med. Biol. 317 1992 139-151
5. J.D. Chapman Measurement of tumor hypoxia by invasive and non-invasive procedures: a review of recent clinical studies Radiother. Oncol 20 suppl 1991 13-19
6. E.J. Hall Radiobiology for the radiologist 4th ed. 1994 Lippincott Philadelphia
7. R.A. Gatenby H.B. Kessler J.S. Rosenblum et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 14 1988 831-838
8. F. Kallinowski R. Zander M. Hoeckel et al. Tumor tissue oxygenation as evaluated by computerized-pO2-histography Int. J. Radiat. Oncol. Biol. Phys. 19 1990 953-961
9. D.M. Brizel G.S. Sibley L.R. Prosnitz et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck Int. J. Radiat. Oncol. Biol. Phys. 38 1997 285-289
10. M. Nordsmark M. Overgaard J. Overgaard Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck Radiother. Oncol. 41 1996 31-30
11. P. Stadler A. Becker H.J. Feldmann et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer Int. J. Radiat. Oncol. Biol. Phys. 44 1999 749-754
12. F. Eschwege J. Bourhis T. Girinski et al. Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: a review of the Institute Gustave Roussy experience Int. J. Radiat. Oncol. Biol. Phys. 39 1997 849-853
13. K. Sundfor H. Lyng C.G. Trope et al. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization Radiother. Oncol. 54 2000 101-107
14. A.W. Fyles M. Milosevic R. Wong et al. Oxygenation predicts radiation response and survival in patients with cervix cancer Radiother. Oncol. 48 1998 149-156
15. T.H. Knocke H.D. Weitmann H.J. Feldmann et al. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix Radiother. Oncol. 53 1999 99-104
16. M. Hockel K. Schlenger B. Aral et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix Cancer Res. 56 1996 4509-4515
17. M. Nordsmark J. Alsner J. Keller et al. Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations Br. J. Cancer 84 2001 1070-1075
18. B.A. Teicher J.S. Lazo A.C. Sartorelli Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells Cancer Res. 41 1981 73-81
19. P.J. O'Dwyer K.S. Yao P. Ford et al. Effects of hypoxia on detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells Cancer Res. 54 1994 3082-3087
20. G.C. Rice C. Hoy R.T. Schimke Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells Proc. Natl. Acad. Sci. USA 83 1986 5978-5982
21. R. Rodriguez M.A. Ritter J.F. Fowler et al. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo Int. J. Radiat. Oncol. Biol. Phys. 29 1994 105-113
22. R.E. Durand The influence of microenvironmental factors during cancer therapy In Vivo 8 1994 691-702
23. M. Hockel K. Schlenger S. Hockel et al. Hypoxic cervical cancers with low apoptotic index are highly aggressive Cancer Res. 59 1999 4525-4528
24. D.M. Brizel S.P. Scully J.M. Harrelson et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma Cancer Res. 56 1996 941-943
25. T.G. Graeber C. Osmanian T. Jacks et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours Nature 379 1996 88-91
26. G.U. Dachs G.M. Tozer Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation Eur. J. Cancer. 36 2000 1649-1660
27. T.Y. Reynolds S. Rockwell P.M. Glazer Genetic instability induced by the tumor microenvironment Cancer Res. 56 1996 5754-5777
28. C. Blancher A.L. Harris The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target Cancer Metastasis Rev. 17 1998 187-194
29. H.M. Sowter P.J. Ratcliffe P. Watson et al. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors Cancer Res. 61 2001 6669-6673
30. M. Hockel P. Vaupel Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects J. Natl. Cancer Inst. 93 2001 266-276
31. M. Hockel K. Schlenger C. Knoop et al. Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements Cancer Res. 51 1991 6098-6102
32. M. Hockel P. Vaupel Biological consequences of tumor hypoxia Semin. Oncol. 28 2001 36-41
33. P.W. Vaupel M. Hockel Oxygenation status of human tumours: a reappraisal using computerised histography In: P.W. Vaupel (Ed.) Tumour reoxygenation 1995 Gustav Fischer Verlag Marburg, Germany 219-232
34. M. Nordsmark S.M. Bentzen J. Overgaard Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity Acta Oncol. 33 1994 383-389
35. P. Davies F., Brink Jr. Microelectrodes for measuring local oxygen tensions in animal tissue Rev. Sci. Instrum. 13 1942 524-528
36. M. Hockel C. Knoop K. Schlenger et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix Radiother. Oncol. 26 1993 45-50
37. H.B. Stone J.M. Brown T.L. Phillips et al. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland Radiat. Res. 136 1993 422-434
38. P.L. Olive J.P. Banath C. Aquino-Parsons Measuring hypoxia in solid tumours - is there a gold standard? Acta Oncol. 40 2001 917-923
39. M. Nozue I. Lee F. Yuan et al. Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic marker J. Surg. Oncol. 66 1997 30-38
40. H. Lyng K. Sundfor E.K. Rofstad Oxygen tension in human tumours measured with polarographic needle electrodes and its relationship to vascular density, necrosis and hypoxia Radiother. Oncol. 44 1997 163-169
41. E. Lartigau F. Lespinasse L. Vitu et al. Does the direct measurement of oxygen tension in tumors have any adverse effects? Int. J. Radiat. Oncol. Biol. Phys. 22 1992 949-951
42. C.M. Doll M. Milosevic M. Pintilie et al. Estimating hypoxic status in human tumors: a simulation using Eppendorf oxygen probe data in cervical cancer patients Int. J. Radiat. Oncol. Biol. Phys. 55 2003 1239-1246
43. M. Hockel K. Schlenger M. Mitze et al. Hypoxia and radiation response in human tumors Semin. Radiat. Oncol 6 1996 3-9
44. M. Nordsmark J. Loncaster S.C. Chou et al. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma Int. J. Radiat. Oncol. Biol. Phys. 49 2001 581-586
45. K. Sundfor H. Lyng E.K. Rofstad Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix Br. J. Cancer 78 1998 822-827
46. E. Lartigau A.M. Le Ridant P. Lambin et al. Oxygenation of head and neck tumors Cancer 71 1993 2319-2325
47. A. Becker G. Hansgen M. Bloching et al. Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue Int. J. Radiat. Oncol. Biol. Phys. 42 1998 35-41
48. Q.T. Le M.S. Kovacs M.J. Dorie et al. Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients Int. J. Radiat. Oncol. Biol. Phys. 56 2003 375-383
49. D.M. Brizel R.K. Dodge R.W. Clough et al. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome Radiother. Oncol. 53 1999 113-117
50. M. Nordsmark M. Hoyer J. Keller et al. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas Int. J. Radiat. Oncol. Biol. Phys. 35 1996 701-708
51. L. Bentzen S. Keiding M. Nordsmark et al. Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours Radiother. Oncol. 67 2003 339-344
52. D.M. Brizel G.L. Rosner J. Harrelson et al. Pretreatment oxygenation profiles of human soft tissue sarcomas Int. J. Radiat. Oncol. Biol. Phys. 30 1994 635-642
53. M. Nordsmark J. Keller O.S. Nielsen et al. Tumour oxygenation assessed by polarographic needle electrodes and bioenergetic status measured by 31P magnetic resonance spectroscopy in human soft tissue tumours Acta Oncol. 36 1997 565-571
54. E. Lartigau H. Randrianarivelo M.F. Avril et al. Intratumoral oxygen tension in metastatic melanoma Melanoma Res. 7 1997 400-406
55. N. Pappova E. Siracka A. Vacek et al. Oxygen tension and prediction of the radiation response. Polarographic study in human breast cancer Neoplasma 29 1982 669-674
56. P. Vaupel K. Schlenger C. Knoop et al. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements Cancer Res. 51 1991 3316-3322
57. G.S. Cruickshank R.P. Rampling W. Cowans Direct measurement of the PO2 distribution in human malignant brain tumours Adv. Exp. Med. Biol. 345 1994 465-470
58. D.R. Collingridge W.K. Young B. Vojnovic et al. Measurement of tumor oxygenation: a comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensor Radiat. Res. 147 1997 329-334
59. B. Movsas J.D. Chapman A.L. Hanlon et al. Hypoxia in human prostate carcinoma: an Eppendorf PO2 study Am. J. Clin. Oncol. 24 2001 458-461
60. S.M. Evans A.V. Kachur C.Y. Shiue et al. Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1 J. Nucl. Med. 41 2000 327-336
61. C.J. Koch Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5 Methods Enzymol. 352 2002 3-31
62. R.E. Airley J. Loncaster J.A. et al. Raleigh GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding Int. J. Cancer. 104 2003 85-91
63. B.W. Pogue K.D. Paulsen J.A. O'Hara et al. Estimation of oxygen distribution in RIF-1 tumors by diffusion model-based interpretation of pimonidazole hypoxia and eppendorf measurements Radiat. Res. 155 2001 15-25
64. P.L. Olive DNA damage and repair in individual cells: applications of the comet assay in radiobiology Int. J. Radiat. Biol. 75 1999 395-405
65. D.W. Fairbairn P.L. Olive K.L. O'Neill The comet assay: a comprehensive review Mutat. Res. 339 1995 37-59
66. M.C. Kavanagh A. Sun Q. Hu et al. Comparing techniques of measuring tumor hypoxia in different murine tumors: Eppendorf pO2 Histograph, [3H]misonidazole binding and paired survival assay Radiat. Res. 145 1996 491-500
67. C. Aquino-Parsons C. Luo C.M. Vikse Comparison between the comet assay and the oxygen microelectrode for measurement of tumor hypoxia Radiother. Oncol. 51 1999 179-185
68. K.A. Furger R.K. Menon A.B. Tuckl et al. The functional and clinical roles of osteopontin in cancer and metastasis Curr. Mol. Med. 1 2001 621-632
69. Q.T. Le P.D. Sutphin S. Raychaudhuri et al. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas Clin. Cancer Res. 9 2003 59-67
70. D.P. Bottaro L.A. Liotta Cancer: out of air is not out of action Nature 423 2003 593-595
71. T.J. Yeatman A.F. Chambers Osteopontin and colon cancer progression Clin. Exp. Metastasis. 20 2003 85-90
72. C.L. McCoy D.J. McIntyre S.P. Robinson et al. Magnetic resonance spectroscopy and imaging methods for measuring tumour and tissue oxygenation Br. J. Cancer 27 suppl 1996 S226-S231
73. S. Ogawa T.M. Lee A.R. Kay et al. Brain magnetic resonance imaging with contrast dependent on blood oxygenation Proc. Natl. Acad. Sci. U S A 87 1990 9868-9872
74. J.H. Duyn C.T. Moonen G.H. van Yperen et al. Inflow versus deoxyhemoglobin effects in BOLD functional MRI using gradient echoes at 1.5 T. NMR Biomed 7 1994 83-88
75. J.R. Griffiths N.J. Taylor F.A. Howe et al. The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging Int. J. Radiat. Oncol. Biol. Phys. 39 1997 697-701
76. S.P. Robinson D.R. Collingridge F.A. Howe et al. Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging NMR Biomed. 12 1999 98-106
77. S.P. Robinson L.M. Rodrigues F.A. Howe et al. Effects of different levels of hypercapnic hyperoxia on tumour R(2)* and arterial blood gases Magn. Reson. Imaging 19 2001 161-166
78. M. Rijpkema J.H. Kaanders F.B. Joosten et al. Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging Int. J. Radiat. Oncol. Biol. Phys. 53 2002 1185-1191
79. C. Baudelet B. Gallez How does blood oxygen level-dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors? Magn. Reson. Med. 48 2002 980-986
80. J.S. Taylor P.S. Tofts R. Port et al. MR imaging of tumor microcirculation: promise for the new millennium Magn. Reson. Imaging. 10 1999 903-907
81. F. Goda G. Bacic J.A. O'Hara et al. The relationship between partial pressure of oxygen and perfusion in two murine tumors after X-ray irradiation: a combined gadopentetate dimeglumine dynamic magnetic resonance imaging and in vivo electron paramagnetic resonance oximetry study Cancer Res. 56 1996 3344-3349
82. R.A. Cooper B.M. Carrington J.A. Loncaster et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix Radiother. Oncol. 57 2000 53-59
83. N.A. Mayr W.T. Yuh J. Zheng et al. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging AJR 170 1998 177-182
84. H. Hawighorst P.G. Knapstein M.V. Knopp et al. Uterine cervical carcinoma: Comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival Cancer Res. 58 1998 3598-3602
85. T. Jue U. Kreutzer Y Chung 1H NMR approach to observe tissue oxygenation with the signals of myoglobin Adv. Exp. Med. Biol. 361 1994 111-118
86. D.C. Shungu Z.M. Bhujwalla J.P. Wehrle et al. 1H NMR spectroscopy of subcutaneous tumors in mice: preliminary studies of effects of growth, chemotherapy and blood flow reduction NMR Biomed. 5 1992 296-302
87. J.W. Berkelbach van der Sprenkel P.R. Luyten P.C. van Rijen et al. Cerebral lactate detected by regional proton magnetic resonance spectroscopy in a patient with cerebral infarction Stroke 19 1988 1556-1560
88. H. Bruhn J. Frahm M.L. Gyngell et al. Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy Magn. Reson. Med. 9 1989 126-131
89. J.M. Star-Lack E. Adalsteinsson M.F. Adam et al. In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements AJNR 21 2000 183-193
90. P. Vaupel C. Schaefer P. Okunieff Intracellular acidosis in murine fibrosarcomas coincides with ATP depletion, hypoxia, and high levels of lactate and total Pi NMR Biomed. 7 1994 128-136
91. G.M. Tozer J.R. Griffiths The contribution made by cell death and oxygenation to 31P MRS observations of tumour energy metabolism NMR Biomed. 5 1992 279-289
92. D.R. Olsen E.K. Rofstad Monitoring of tumor reoxygenation following irradiation by 31P magnetic resonance spectroscopy: an experimental study of human melanoma xenografts Radiother. Oncol. 52 1999 261-267
93. J. Saitoh H. Sakurai Y. Suzuki et al. Correlations between in vivo tumor weight, oxygen pressure, 31P NMR spectroscopy, hypoxic microenvironment marking by beta-D-iodinated azomycin galactopyranoside (beta-D-IAZGP), and radiation sensitivity Int. J. Radiat. Oncol. Biol. Phys. 54 2002 903-909
94. G.F. Whitmore A.J. Varghese The biological properties of reduced nitroheterocyclics and possible underlying biochemical mechanisms Biochem. Pharmacol. 35 1986 97-103
95. J.D. Chapman A.J. Franko J. Sharplin A marker for hypoxic cells in tumours with potential clinical applicability Br. J. Cancer. 43 1981 546-550
96. R.J. Maxwell P. Workman J.R. Griffiths Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivo Int. J. Radiat. Oncol. Biol. Phys. 16 1989 925-929
97. G.Y. Jin S.J. Li J.E. Moulder et al. Dynamic measurements of hexafluoromisonidazole (CCI-103F) retention in mouse tumours by 1H/19F magnetic resonance spectroscopy Int. J. Radiat. Biol. 58 1990 1025-1034
98. J.A. Raleigh A.J. Franko D.A. Kelly et al. Development of an in vivo 19F magnetic resonance method for measuring oxygen deficiency in tumors Magn. Reson. Med. 22 1991 451-466
99. L. Kwock M. Gill H.L. McMurry et al. Evaluation of a fluorinated 2-nitroimidazole binding to hypoxic cells in tumor-bearing rats by 19F magnetic resonance spectroscopy and immunohistochemistry Radiat. Res. 129 1992 71-78
100. B.M. Seddon R.J. Maxwell D.J. Honess et al. Validation of the fluorinated 2-nitroimidazole SR-4554 as a noninvasive hypoxia marker detected by magnetic resonance spectroscopy Clin. Cancer Res. 8 2002 2323-2335
101. E.O. Aboagye R.J. Maxwell M.R. Horsman et al. The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554 Br. J. Cancer 77 1998 65-70
102. E.O. Aboagye A.B. Kelson M. Tracy Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography Anticancer Drug Des. 13 1998 703-730
103. R.P. Mason H. Shukla P.P. Antich In vivo oxygen tension and temperature: simultaneous determination using 19F NMR spectroscopy of perfluorocarbon Magn. Reson. Med. 29 1993 296-302
104. S.K. Holland R.P. Kennan M.M. Schaub et al. Imaging oxygen tension in liver and spleen by 19F NMR Magn. Reson. Med. 29 1993 446-458
105. R.P. Mason W. Rodbumrung P.P. Antich Hexafluorobenzene: a sensitive 19F NMR indicator of tumor oxygenation NMR Biomed. 9 1996 125-134
106. D. Zhao A. Constantinescu L. Jiang et al. Prognostic radiology: quantitative assessment of tumor oxygen dynamics by MRI Am. J. Clin. Oncol. 24 2001 462-466
107. Y. Song A. Constantinescu R.P. Mason Dynamic breast tumor oximetry: the development of prognostic radiology Technol. Cancer Res. Treat. 1 2002 471-478
108. P. Kuppusamy R.A. Shankar J.L. Zweier In vivo measurement of arterial and venous oxygenation in the rat using 3D spectral-spatial electron paramagnetic resonance imaging Phys. Med. Biol. 43 1998 1837-1844
109. H.M. Swartz Principles of the metabolism of nitroxides and their implications for spin trapping Free Radic. Res. Commun. 9 1990 399-405
110. K. Chen J.F. Glockner P.D. Morse et al. 2nd Effects of oxygen on the metabolism of nitroxide spin labels in cells Biochemistry 28 1989 2496-2501
111. B. Gallez G. Bacic F. Goda et al. Use of nitroxides for assessing perfusion, oxygenation, and viability of tissues: in vivo EPR and MRI studies Magn. Reson. Med. 35 1996 97-106
112. J.A. O'Hara F. Goda E. Demidenko et al. Effect on regrowth delay in a murine tumor of scheduling split-dose irradiation based on direct pO2 measurements by electron paramagnetic resonance oximetry Radiat. Res. 150 1998 549-556
113. B.F. Jordan P. Misson R. Demeure et al. Changes in tumor oxygenation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI Int. J. Radiat. Oncol. Biol. Phys. 48 2000 565-570
114. B.B. Williams H. al Hallaq G.V. Chandramouli et al. Imaging spin probe distribution in the tumor of a living mouse with 250 MHz EPR: correlation with BOLD MRI Magn. Reson. Med. 47 2002 634-638
115. P. Kuppusamy M. Afeworki R.A. Shankar et al. In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model Cancer Res. 58 1998 1562-1568
116. H.J. Halpern C. Yu M. Peric et al. Oxymetry deep in tissues with low-frequency electron paramagnetic resonance Proc. Natl. Acad. Sci. U S A 91 1994 13047-13051
117. J.F. Dunn J.A. O'Hara Y. Zaim-Wadghiri et al. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study J. Magn. Reson. Imaging 16 2002 511-521
118. H.J. Tochon-Danguy J.I. Sachinidis F. Chan et al. Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO) Nucl. Med. Biol. 29 2002 191-197
119. J.S. Rasey N.J. Nelson L. Chin et al. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro Radiat. Res. 122 1990 301-308
120. W.J. Koh J.S. Rasey M.L. Evans et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole Int. J. Radiat. Oncol. Biol. Phys. 22 1992 199-212
121. J.S. Rasey W.J. Koh M.L. Evans et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients Int. J. Radiat. Oncol. Biol. Phys. 36 1996 417-428
122. 18F)FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression Eur. J. Nucl. Med. Mol. Imaging 30 2003 695-704
123. W.J. Koh K.S. Bergman J.S. Rasey et al. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography Int. J. Radiat. Oncol. Biol. Phys. 33 1995 391-398
124. D. Rischin L. Peters R. Hicks et al. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer J. Clin. Oncol. 19 2001 535-542
125. A.M. Scott S. Ramdave A. Hannah et al. Correlation of hypoxic cell fraction with glucose metabolic rate in gliomas with 18 F-fluoromisonidazole(FMISO) and 18 F-fluorodeoxyglucose (FDG) positron emission tomography J. Nucl. Med. 42 2001 678P
126. 18F-fluorodeoxyglucose (FDG) positron emission tomography J. Nucl. Med. 42 2001 678P
127. J.L. Dearling J.S. Lewis G.E. Mullen et al. Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro Eur. J. Nucl. Med. 25 1998 788-792
128. J.S. Lewis M.J. Welch PET imaging of hypoxia Q. J. Nucl. Med. 45 2001 183-188
129. N. Takahashi Y. Fujibayashi Y. Yonekura et al. Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer Ann. Nucl. Med. 14 2000 323-328
130. 60Cu]ATSM in human neoplasms J. Nucl. Med. 41 2000 58P
131. F. Dehdashti M.A. Mintun J.S. Lewis et al. Evaluation of tumour hypoxia with Cu-60-ATSM and PET J. Nucl. Med. 41 2000 34P
132. 18F] Fluoroerthronitroimidazole PET J. Nucl. Med. 42 2001 1643-1652
133. T. Gronroos O. Eskola K. Lehtio et al. Pharmacokinetics of [18F]FETNIM: a potential marker for PET J. Nucl. Med. 42 2001 1397-1404
134. R.C. Urtasun M.B. Parliament A.J. McEwan et al. Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside Br. J. Cancer 27 suppl 1996 S209-S212
135. M.B. Parliament J.D. Chapman R.C. Urtasun et al. Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study Br. J. Cancer 65 1992 90-95
136. D. Groshar A.J. McEwan M.B. et al. Parliament Imaging tumor hypoxia and tumor perfusion J. Nucl. Med. 34 1993 885-888
137. R.V. Iyer E. Kim R.F. Schneider et al. A dual hypoxic marker technique for measuring oxygenation change within individual tumors Br. J. Cancer 78 1998 163-169
138. M.C. Hulshof C.J. Rehmann J. Booij et al. Lack of perfusion enhancement after administration of nicotinamide and carbogen in patients with glioblastoma: a 99mTc-HMPAO SPECT study Radiother. Oncol. 48 1998 135-142
139. Melo T. Ballinger J. Rauth A.M. Comparison of MMS 181321 and BMS 194796, nitoimidazoles labeled with Technetium-99m, as markers for tumour hypoxia 45th Annual Meeting of the Radiation Research Society. Provence, RI 1997.
140. C. Archer B. Edwards N. Powell Radiopharmaceuticals for imaging hypoxia In: S. Mather (Ed.) Current directions in radiopharmaceutical research and development 1996 Kluwer Academic Dordrecht, The Netherlands 81-88
141. J.R. Ballinger J.W. Kee A.M. Rauth In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia J. Nucl. Med. 37 1996 1023-1031
142. T. Melo J. Duncan J.R. Ballinger et al. BRU59-U21, a second-generation 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors J. Nucl. Med. 41 2000 169-176
143. F.J. Hoebers H.L. Janssen A.V. Olmos et al. Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU59-21 Eur. J. Nucl. Med. Mol. Imaging 29 2002 1206-1211
144. D.J. Honess S.A. Hill D.R. Collingridge et al. Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo Int. J. Radiat. Oncol. Biol. Phys. 42 1998 731-735
145. J.M. Brown M.J. Lemmon Tumor hypoxia can be exploited to preferentially sensitize tumors to fractionated irradiation Int. J. Radiat. Oncol. Biol. Phys. 20 1991 457-461
146. M.J. Dorie J.M. Brown Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine Cancer Chemother. Pharmacol. 39 1997 361-366
147. G.U. Dachs D.J. Chaplin Microenvironmental control of gene expression: implications for tumor angiogenesis, progression, and metastasis Semin. Radiat. Oncol. 8 1998 208-216
148. G.U. Dachs A.V. Patterson J.D. Firth et al. Targeting gene expression to hypoxic tumor cells Nat. Med. 3 1997 515-520
149. K.J. Williams R.L. Cowen I.J. Stratford Tumour hypoxia - therapeutic considerations Breast Cancer Res. 3 2001 328-331